Loading...
Milestone Scientific Inc.
MLSS•AMEX
Healthcare
Medical - Instruments & Supplies
$0.59
$-0.00(-0.82%)
Milestone Scientific Inc. (MLSS) Financial Performance & Income Statement Overview
Review Milestone Scientific Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-12.19%
↓ 12.19%
Operating Income Growth
4.92%
↑ 4.92%
Net Income Growth
31.97%
↑ 31.97%
Operating Cash Flow Growth
45.18%
↑ 45.18%
Operating Margin
-114.24%
↓ 114.24%
Gross Margin
100.39%
↑ 100.39%
Net Profit Margin
-82.55%
↓ 82.55%
ROE
-82.73%
↓ 82.73%
ROIC
-156.96%
↓ 156.96%
Milestone Scientific Inc. (MLSS) Income Statement & Financial Overview
Review Milestone Scientific Inc.'s (MLSS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.01M | $2.51M | $1.85M | $2.25M |
| Cost of Revenue | $502452.00 | $677585.00 | $442560.00 | $584424.00 |
| Gross Profit | $1.51M | $1.84M | $1.41M | $1.66M |
| Gross Profit Ratio | $0.75 | $0.73 | $0.76 | $0.74 |
| R&D Expenses | $217532.00 | $232056.00 | $314968.00 | $94211.00 |
| SG&A Expenses | $3.33M | $3.06M | $2.87M | $3.04M |
| Operating Expenses | $3.55M | $3.31M | $3.18M | $3.13M |
| Total Costs & Expenses | $4.06M | $3.98M | $3.63M | $3.71M |
| Interest Income | $0.00 | $8008.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $3351.00 |
| Depreciation & Amortization | $33959.00 | $8574.00 | $31524.00 | $36148.00 |
| EBITDA | -$2.008M | -$1.46M | -$1.75M | -$1.43M |
| EBITDA Ratio | -$1.00 | -$0.58 | -$0.94 | -$0.64 |
| Operating Income | -$2.04M | -$1.47M | -$1.78M | -$1.47M |
| Operating Income Ratio | -$1.01 | -$0.58 | -$0.96 | -$0.65 |
| Other Income/Expenses (Net) | $6752.00 | $8008.00 | $2.004M | $24539.00 |
| Income Before Tax | -$2.04M | -$1.46M | $223638.00 | -$1.44M |
| Income Before Tax Ratio | -$1.01 | -$0.58 | $0.12 | -$0.64 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $2.00 |
| Net Income | -$2.04M | -$1.46M | $223638.00 | -$1.44M |
| Net Income Ratio | -$1.01 | -$0.58 | $0.12 | -$0.64 |
| EPS | -$0.03 | -$0.02 | $0.003 | -$0.02 |
| Diluted EPS | -$0.03 | -$0.02 | $0.003 | -$0.02 |
| Weighted Avg Shares Outstanding | $79.79M | $79.97M | $79.97M | $79.74M |
| Weighted Avg Shares Outstanding (Diluted) | $79.79M | $79.97M | $79.97M | $79.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan